Edward Gillis
Equibles does not estimate personal net worth.
Get an email with a short summary when BioCardia, Inc. publishes a filing, an earnings call transcript or a press release.
Get BCDA alertsAbout Edward Gillis
The proxy statement of BioCardia, Inc. reports total compensation of $251,804 for Edward Gillis in fiscal 2024, including a base salary of $251,804. Disclosed compensation is on record for 5 fiscal years. BioCardia, Inc. is classified in the Biotechnology industry within the Healthcare sector. Other leadership on record at BioCardia, Inc. includes Peter Altman (CEO and Board Member), David McClung (CFO) and Marvin Slosman (Board Member).
Affiliation history
-
BioCardia, Inc. (BCDA)
Proxy statement
CurrentStart not stated–present
Last confirmed November 3, 2025
Company network
Leadership on record at BioCardia, Inc.
- Peter Altman CEO, Board Member
- David McClung CFO
- Marvin Slosman Board Member
Executive compensation
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2024 | BioCardia, Inc. (BCDA) | Senior Vice President, Devices | $251,804 | $251,804 |
| 2023 | BioCardia, Inc. (BCDA) | Senior Vice President, Devices | $263,096 | $326,371 |
| 2022 | BioCardia, Inc. (BCDA) | Senior Vice President, Devices | $271,000 | $389,704 |
| 2021 | BioCardia, Inc. (BCDA) | Senior Vice President, Devices | $267,792 | $459,716 |
| 2020 | BioCardia, Inc. (BCDA) | Senior Vice President, Devices | $156,500 | $285,438 |
Recent activity
No call appearances or filed executive changes recorded yet.